Generated: December 11, 2017
DrugPatentWatch Database Preview
Ciclopirox - Generic Drug Details
« Back to Dashboard
What are the generic drug sources for ciclopirox and what is the scope of ciclopirox freedom to operate?
is the generic ingredient in three branded drugs marketed by Fougera Pharms, G And W Labs Inc, Glenmark Pharms, Perrigo New York, Taro, Medimetriks Pharms, Cnty Line Pharms, Glenmark Generics, Paddock Llc, Actavis Mid Atlantic, Perrigo Co, Medicis, Akorn, Apotex Inc, Cipla Ltd, G And W Labs, Hi Tech Pharma, Mylan Pharms Inc, Taro Pharm Inds, Teva Pharms, Tolmar, and Valeant Bermuda, and is included in thirty-one NDAs. There are four patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
Ciclopirox has eighty-six patent family members in thirty-four countries.
There are ten drug master file entries for ciclopirox. Twenty-one suppliers are listed for this compound.
Pharmacology for ciclopirox
|Apotex Inc||CICLOPIROX||ciclopirox||SOLUTION;TOPICAL||078172-001||Sep 18, 2007||AT||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Fougera Pharms||CICLOPIROX||ciclopirox||SUSPENSION;TOPICAL||076422-001||Aug 6, 2004||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Medicis||LOPROX||ciclopirox||SHAMPOO;TOPICAL||021159-001||Feb 28, 2003||AT||RX||Yes||Yes||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Taro Pharm Inds||CICLOPIROX||ciclopirox||SOLUTION;TOPICAL||078144-001||Sep 18, 2007||AT||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Fougera Pharms||CICLOPIROX||ciclopirox||CREAM;TOPICAL||076435-001||Dec 29, 2004||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Tolmar||CICLOPIROX||ciclopirox||SOLUTION;TOPICAL||077687-001||Sep 18, 2007||AT||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Glenmark Generics||CICLOPIROX||ciclopirox||GEL;TOPICAL||091595-001||Feb 29, 2012||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Perrigo New York||CICLOPIROX||ciclopirox||SOLUTION;TOPICAL||077623-001||Sep 18, 2007||AT||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Perrigo New York||CICLOPIROX||ciclopirox||SUSPENSION;TOPICAL||077676-001||Dec 15, 2006||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Valeant Bermuda||PENLAC||ciclopirox||SOLUTION;TOPICAL||021022-001||Dec 17, 1999||AT||RX||Yes||Yes||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Expired Orange Book Patents for Generic Ingredient: ciclopirox
International Patent Family for Ingredient: ciclopirox
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.